Genus, Meet Species: Court Weighs Novo Nordisk’s Semaglutide Patent
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
semaglutide
2 articles
Dr Reddy’s Semaglutide Exports to Continue as Court Denies Interim Relief to Novo Nordisk
The Delhi High Court refused Novo Nordisk interim relief against Dr Reddy’s, finding that the Semaglutide species patent faces serious validity challenges in light of the earlier genus…